Synergism between non-O blood group and oral ... [Thromb Haemost. 2008] - PubMed

Save items

loading

Related citations in PubMed

Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women. [Clin Pharmacol Ther. 2011]
Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J, Cabaret O, Canonico M, Verstuyft C, Dubert L, Becquemont L, Guiochon-Mantel A, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Clin Pharmacol Ther. 2011 Jan; 89(1):60-4. Epub 2010 Nov 24.
Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women. [Arterioscler Thromb Vasc Biol....]
Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Rosendaal FR, Psaty BM. Arterioscler Thromb Vasc Biol. 2006 Dec; 26(12):2807-12. Epub 2006 Sep 14.
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. [J Thromb Haemost. 2006]
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, et al. J Thromb Haemost. 2006 Jun; 4(6):1259-65.
Review Hormone therapy and risk of venous thromboembolism among postmenopausal women. [Climacteric. 2009]
Review Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M, Scarabin PY. Climacteric. 2009; 12 Suppl 1:76-80.
Review Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. [Curr Opin Hematol. 2010]
Review Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
Olié V, Canonico M, Scarabin PY. Curr Opin Hematol. 2010 Sep; 17(5):457-63.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Synergism between non-O blood group and oral estrogen in the risk of venous thro...
Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Thromb Haemost. 2008 Jan ;99(1):246-8. doi: 10.1160/TH07-09-0536.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information